SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Chile
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Banmedica S.A.

Main Activities: Funds, Trusts, and Other Financial Vehicles

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Banmedica S.A.

Headquarters
Blvd. Apoquindo 3600, Floor 1; La Reina; Metropolitana; 7850000
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Fiscal ID (RUT): 965289909
Fiscal ID (ISIN CODE ): CLP1583M1072
Financial Auditors: PricewaterhouseCoopers (2011)
Incorporation Date: August 26, 1988
Total Employees: 8

Tel: +56 2 3533300

Company Description

Banmedica S.A. is a Santiago based company, founded in 1988, and with more than 8 workers. Its engage in the financial area, providing intermediation health related services.During the 20 years of its existence the company has been able to take a 22% market share for its 590,000 clienetes, 80 branches, Call Center with 1.5 million calls a year and a variety of health services.

Company Analysis

According to the Consolidated - Audited financial statement for the first two cumulated quarters of 2012, total net operating revenues increased with 13.39%, from CLP 386,392,772 thousands to CLP 438,142,445 thousands. Operating result increased from CLP 40,618,253 thousands to CLP 45,138,572 thousands which means 11.13% change. The results of the period increased 2.93% reaching CLP 29,847,021 thousands at the end of the period against CLP 28,998,514 thousands last year. Return on equity (Net income/Total equity) went from 17.13% to 15.87%, the Return On Asset (Net income / Total Asset) went from 5.24% to 4.74% and the Net Profit Margin (Net Income/Net Sales) went from 7.50% to 6.81% when compared to the same period of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 0.69 to 0.78 when compared to the previous year.

Key Executives

Carlos Kubik Castro General Manager
Eduardo Urrutia Business Development Manager
Javier Eguiguren Human Resources Manager
Carolis Celis Manager

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

644,598,119

629,203,194

Current Assets

212,384,757

210,102,803

Total Liabilities

455,817,398

441,187,263

Shareholders Equity

188,780,721

188,015,931

Current Liabilities

277,498,325

269,169,375

* All the accounts are in CLP.
Income Statement

Total Operating Revenue

61,105,232

45,138,572

Operational Profit (Loss)

61,105,232

45,138,572

Net Profit (Loss)

41,034,719

29,847,021

* All the accounts are in CLP.
Ratios
Profitability Ratios

Return on Assets (ROA)

6.37%

4.74%

Return on Equity (ROE)

21.74%

15.87%

Return on Sales (ROS)

6.27%

6.94%

Gross Profit Margin

23.79%

24.65%

Operating Profit Margin

9.34%

10.49%

Efficiency Ratios

Accounts Receivable Turnover

5.17x

3.42x

Inventory Turnover

99.00x

67.39x

Current asset turnover

3.08x

2.05x

Fixed-asset turnover

1.51x

1.03x

Asset Turnover

1.01x

0.68x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

61,105,232

45,138,572

Enterprise value

1,208,824,363

1,148,561,501

Bookvalue (BV)

1,072,181,351

1,041,900,983

Net Cash

-244,763,791

-240,241,533

Liquidity Ratios

Current Ratio

76.54%

78.06%

Quick ratio

74.72%

76.27%

Doom's day ratio

11.8%

10.75%

Leverage Ratios

Leverage ratio

141.42%

142.62%

Debt to equity

241.45%

234.65%

Debt to total assets

70.71%

70.12%

Long Term Debt to Capital

48.58%

47.78%